Northern Trust Corp boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 14.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 662,459 shares of the company’s stock after acquiring an additional 81,665 shares during the quarter. Northern Trust Corp owned about 1.10% of HealthEquity worth $33,010,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of HQY. Alps Advisors Inc. increased its stake in HealthEquity by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 10,729 shares of the company’s stock worth $535,000 after purchasing an additional 28 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in HealthEquity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after purchasing an additional 191 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in HealthEquity by 1.1% in the 2nd quarter. Louisiana State Employees Retirement System now owns 18,100 shares of the company’s stock worth $902,000 after purchasing an additional 200 shares in the last quarter. Arizona State Retirement System increased its stake in HealthEquity by 0.9% in the 2nd quarter. Arizona State Retirement System now owns 23,097 shares of the company’s stock worth $1,151,000 after purchasing an additional 200 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its stake in HealthEquity by 4.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,249 shares of the company’s stock worth $265,000 after purchasing an additional 246 shares in the last quarter. Hedge funds and other institutional investors own 90.97% of the company’s stock.

In related news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $42.00, for a total transaction of $399,000.00. Following the completion of the transaction, the vice president now directly owns 84,500 shares in the company, valued at $3,549,000. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Stephen Neeleman sold 8,500 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $46.65, for a total value of $396,525.00. Following the transaction, the insider now owns 1,000 shares of the company’s stock, valued at $46,650. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 715,683 shares of company stock valued at $36,594,008. 19.00% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Northern Trust Corp Raises Holdings in HealthEquity, Inc. (HQY)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/northern-trust-corp-raises-holdings-in-healthequity-inc-hqy/1635996.html.

HQY has been the topic of a number of analyst reports. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Wednesday, October 11th. TheStreet raised HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. BidaskClub raised HealthEquity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a research note on Tuesday, August 29th. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $61.00 price target on shares of HealthEquity in a research note on Wednesday, September 6th. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $57.17.

HealthEquity, Inc. (NASDAQ:HQY) opened at 50.16 on Tuesday. The stock has a market cap of $3.03 billion, a PE ratio of 74.42 and a beta of 1.80. HealthEquity, Inc. has a 52 week low of $30.34 and a 52 week high of $54.95. The company has a 50-day moving average price of $47.34 and a 200-day moving average price of $46.94.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. The business had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. HealthEquity’s quarterly revenue was up 28.7% on a year-over-year basis. During the same period last year, the company earned $0.16 earnings per share. Analysts anticipate that HealthEquity, Inc. will post $0.71 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.